أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
treo freyðitafla 500 mg/50 mg
viatris aps - acidum acetylsalicylicum; coffeinum - freyðitafla - 500 mg/50 mg
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
gaviscon tuggutafla
nordic drugs ab - aluminium hydroxide; sodium hydrogen carbonate; acidum alginicum - tuggutafla
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
treo freyðitafla 50 mg/ 500 mg
viatris aps - coffeinum; acidum acetylsalicylicum - freyðitafla - 50 mg/ 500 mg
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
treo hindbær freyðitafla 500/50 mg
viatris aps - coffeinum; acidum acetylsalicylicum - freyðitafla - 500/50 mg
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
fucidin-hydrocortison krem 20 + 10 mg
leo pharma a/s* - acidum fusidicum inn; hydrocortisonum acetat - krem - 20 + 10 mg
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
clariscan stungulyf, lausn 0,5 mmól/ml
ge healthcare as - acidum gadotericum inn - stungulyf, lausn - 0,5 mmól/ml
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
clariscan stungulyf, lausn í áfylltri sprautu 0,5 mmól/ml
ge healthcare as - acidum gadotericum inn - stungulyf, lausn í áfylltri sprautu - 0,5 mmól/ml
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
spectracillin filmuhúðuð tafla 875/125 mg
williams & halls ehf. - acidum clavulanicum kalíum; amoxicillinum tríhýdrat - filmuhúðuð tafla - 875/125 mg
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
ursochol (ursodiol) hart hylki 250 mg
orifarm generics a/s - acidum ursodeoxycholicum inn - hart hylki - 250 mg
الاتحاد الأوروبي -
الأيسلاندية -
EMA (European Medicines Agency)
izba
novartis europharm limited - travoprost - ocular hypertension; glaucoma, open-angle - ophthalmologicals, antiglaucoma preparations and miotics - minnkun á hækkun á augnþrýstingi hjá fullorðnum sjúklingum með háþrýsting í hálsi eða augnháðum gláku (sjá kafla 5. lækkun hækkað í auga þrýsting í börn sjúklinga á aldrinum 3 ár að < 18 ára með augu háan blóðþrýsting eða börn gláku.